NCT07128420 - Microneedle Treatment of Chronic Phase Peyronie's Disease: A Pilot Clinical Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 30, 2027

Conditions

Peyronie's Disease

Interventions

DEVICE

Application of 3 sessions of microneedle therapy

"Enrolled study participants will receive 3-4 treatments of microneedling to the affected area.~Study participants will microneedling (Fusion Tip Potenza Fractional Radiofrequency Microneedle Electrosurgical Unit, Jeisys Medical Inc, Seoul, KR) at a depth of 2.0 to 2.75mm."

Trial Locations (1)

Unknown

The Ottawa Hospital, Ottawa